BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

325 related articles for article (PubMed ID: 26765563)

  • 1. Genetic dissection of Down syndrome-associated congenital heart defects using a new mouse mapping panel.
    Lana-Elola E; Watson-Scales S; Slender A; Gibbins D; Martineau A; Douglas C; Mohun T; Fisher EM; Tybulewicz VL
    Elife; 2016 Jan; 5():. PubMed ID: 26765563
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Engineered chromosome-based genetic mapping establishes a 3.7 Mb critical genomic region for Down syndrome-associated heart defects in mice.
    Liu C; Morishima M; Jiang X; Yu T; Meng K; Ray D; Pao A; Ye P; Parmacek MS; Yu YE
    Hum Genet; 2014 Jun; 133(6):743-53. PubMed ID: 24362460
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased dosage of DYRK1A leads to congenital heart defects in a mouse model of Down syndrome.
    Lana-Elola E; Aoidi R; Llorian M; Gibbins D; Buechsenschuetz C; Bussi C; Flynn H; Gilmore T; Watson-Scales S; Haugsten Hansen M; Hayward D; Song OR; Brault V; Herault Y; Deau E; Meijer L; Snijders AP; Gutierrez MG; Fisher EMC; Tybulewicz VLJ
    Sci Transl Med; 2024 Jan; 16(731):eadd6883. PubMed ID: 38266108
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Down syndrome congenital heart disease: a narrowed region and a candidate gene.
    Barlow GM; Chen XN; Shi ZY; Lyons GE; Kurnit DM; Celle L; Spinner NB; Zackai E; Pettenati MJ; Van Riper AJ; Vekemans MJ; Mjaatvedt CH; Korenberg JR
    Genet Med; 2001; 3(2):91-101. PubMed ID: 11280955
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic modifiers predisposing to congenital heart disease in the sensitized Down syndrome population.
    Li H; Cherry S; Klinedinst D; DeLeon V; Redig J; Reshey B; Chin MT; Sherman SL; Maslen CL; Reeves RH
    Circ Cardiovasc Genet; 2012 Jun; 5(3):301-8. PubMed ID: 22523272
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genotype-phenotype correlation for congenital heart disease in Down syndrome through analysis of partial trisomy 21 cases.
    Pelleri MC; Gennari E; Locatelli C; Piovesan A; Caracausi M; Antonaros F; Rocca A; Donati CM; Conti L; Strippoli P; Seri M; Vitale L; Cocchi G
    Genomics; 2017 Oct; 109(5-6):391-400. PubMed ID: 28648597
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetics and Molecular Basis of Congenital Heart Defects in Down Syndrome: Role of Extracellular Matrix Regulation.
    Mollo N; Scognamiglio R; Conti A; Paladino S; Nitsch L; Izzo A
    Int J Mol Sci; 2023 Feb; 24(3):. PubMed ID: 36769235
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Down's syndrome-like cardiac developmental defects in embryos of the transchromosomic Tc1 mouse.
    Dunlevy L; Bennett M; Slender A; Lana-Elola E; Tybulewicz VL; Fisher EM; Mohun T
    Cardiovasc Res; 2010 Nov; 88(2):287-95. PubMed ID: 20558441
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Penetrance of Congenital Heart Disease in a Mouse Model of Down Syndrome Depends on a Trisomic Potentiator of a Disomic Modifier.
    Li H; Edie S; Klinedinst D; Jeong JS; Blackshaw S; Maslen CL; Reeves RH
    Genetics; 2016 Jun; 203(2):763-70. PubMed ID: 27029737
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The complex SNP and CNV genetic architecture of the increased risk of congenital heart defects in Down syndrome.
    Sailani MR; Makrythanasis P; Valsesia A; Santoni FA; Deutsch S; Popadin K; Borel C; Migliavacca E; Sharp AJ; Duriaux Sail G; Falconnet E; Rabionet K; Serra-Juhé C; Vicari S; Laux D; Grattau Y; Dembour G; Megarbane A; Touraine R; Stora S; Kitsiou S; Fryssira H; Chatzisevastou-Loukidou C; Kanavakis E; Merla G; Bonnet D; Pérez-Jurado LA; Estivill X; Delabar JM; Antonarakis SE
    Genome Res; 2013 Sep; 23(9):1410-21. PubMed ID: 23783273
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trisomy 21 induces pericentrosomal crowding delaying primary ciliogenesis and mouse cerebellar development.
    Jewett CE; McCurdy BL; O'Toole ET; Stemm-Wolf AJ; Given KS; Lin CH; Olsen V; Martin W; Reinholdt L; Espinosa JM; Sullivan KD; Macklin WB; Prekeris R; Pearson CG
    Elife; 2023 Jan; 12():. PubMed ID: 36656118
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human chromosome 21 orthologous region on mouse chromosome 17 is a major determinant of Down syndrome-related developmental cognitive deficits.
    Zhang L; Meng K; Jiang X; Liu C; Pao A; Belichenko PV; Kleschevnikov AM; Josselyn S; Liang P; Ye P; Mobley WC; Yu YE
    Hum Mol Genet; 2014 Feb; 23(3):578-89. PubMed ID: 24041763
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Massively parallel sequencing reveals the complex structure of an irradiated human chromosome on a mouse background in the Tc1 model of Down syndrome.
    Gribble SM; Wiseman FK; Clayton S; Prigmore E; Langley E; Yang F; Maguire S; Fu B; Rajan D; Sheppard O; Scott C; Hauser H; Stephens PJ; Stebbings LA; Ng BL; Fitzgerald T; Quail MA; Banerjee R; Rothkamm K; Tybulewicz VL; Fisher EM; Carter NP
    PLoS One; 2013; 8(4):e60482. PubMed ID: 23596509
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Craniofacial dysmorphology in Down syndrome is caused by increased dosage of Dyrk1a and at least three other genes.
    Redhead Y; Gibbins D; Lana-Elola E; Watson-Scales S; Dobson L; Krause M; Liu KJ; Fisher EMC; Green JBA; Tybulewicz VLJ
    Development; 2023 Apr; 150(8):. PubMed ID: 37102702
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Down syndrome mouse models are looking up.
    Reeves RH
    Trends Mol Med; 2006 Jun; 12(6):237-40. PubMed ID: 16677859
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comprehensive phenotypic analysis of the Dp1Tyb mouse strain reveals a broad range of Down syndrome-related phenotypes.
    Lana-Elola E; Cater H; Watson-Scales S; Greenaway S; Müller-Winkler J; Gibbins D; Nemes M; Slender A; Hough T; Keskivali-Bond P; Scudamore CL; Herbert E; Banks GT; Mobbs H; Canonica T; Tosh J; Noy S; Llorian M; Nolan PM; Griffin JL; Good M; Simon M; Mallon AM; Wells S; Fisher EMC; Tybulewicz VLJ
    Dis Model Mech; 2021 Oct; 14(10):. PubMed ID: 34477842
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human chromosome 21q22.2-qter carries a gene(s) responsible for downregulation of mlc2a and PEBP in Down syndrome model mice.
    Kazuki Y; Kimura M; Nishigaki R; Kai Y; Abe S; Okita C; Shirayoshi Y; Schulz TC; Tomizuka K; Hanaoka K; Inoue T; Oshimura M
    Biochem Biophys Res Commun; 2004 Apr; 317(2):491-9. PubMed ID: 15063784
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic analysis of Down syndrome-associated heart defects in mice.
    Liu C; Morishima M; Yu T; Matsui S; Zhang L; Fu D; Pao A; Costa AC; Gardiner KJ; Cowell JK; Nowak NJ; Parmacek MS; Liang P; Baldini A; Yu YE
    Hum Genet; 2011 Nov; 130(5):623-32. PubMed ID: 21442329
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The pattern of congenital heart defects arising from reduced Tbx5 expression is altered in a Down syndrome mouse model.
    Polk RC; Gergics P; Steimle JD; Li H; Moskowitz IP; Camper SA; Reeves RH
    BMC Dev Biol; 2015 Jul; 15():30. PubMed ID: 26208718
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mice containing a human chromosome 21 model behavioral impairment and cardiac anomalies of Down's syndrome.
    Shinohara T; Tomizuka K; Miyabara S; Takehara S; Kazuki Y; Inoue J; Katoh M; Nakane H; Iino A; Ohguma A; Ikegami S; Inokuchi K; Ishida I; Reeves RH; Oshimura M
    Hum Mol Genet; 2001 May; 10(11):1163-75. PubMed ID: 11371509
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.